Patent · US Active

Compounds for the treatment of proliferative disorders

US8269017B2 · kind B2 · utility

3Cited by

19References

20Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Lijun Sun · Harvard, US
Christopher Borella · Bedford, US
Hao Li · Brookline, US
Jun Jiang · Shanghai, CN
Shoujun Chen · Bedford, US
Keizo Koya · Sharon, US
Takayo Inoue · Tokyo, JP
Zhenjian Du · Northborough, US
Kevin Foley · Waltham, US
Yaming Wu · Shanghai, CN
Mei Zhang · Shanghai, CN
Weiwen Ying · Ayer, US

Key dates

Filing date	Sep 16, 2010
Grant date	Sep 18, 2012
Priority date	—
Expiry date	Sep 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/653
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of structural formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.